- Home
- Publications
- Publication Search
- Publication Details
Title
Leishmaniasis
Authors
Keywords
-
Journal
Human vaccines & immunotherapeutics
Volume 7, Issue 11, Pages 1204-1214
Publisher
Informa UK Limited
Online
2011-12-02
DOI
10.4161/hv.7.11.17752
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KSAC, the First Defined Polyprotein Vaccine Candidate for Visceral Leishmaniasis
- (2011) Yasuyuki Goto et al. Clinical and Vaccine Immunology
- Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis
- (2011) Shet Masih et al. EXPERIMENTAL PARASITOLOGY
- Vaccines for Leishmaniasis: From proteome to vaccine candidates
- (2011) Juliane Schroeder et al. Human vaccines & immunotherapeutics
- Vaccine candidates for leishmaniasis: A review
- (2011) Rajeev Nagill et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The protective effect against Leishmania infection conferred by sand fly bites is limited to short-term exposure
- (2011) Iva Rohoušová et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice
- (2011) D. DOROUD et al. PARASITE IMMUNOLOGY
- Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
- (2011) Saumyabrata Mazumder et al. PLoS One
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- Vaccines for the Leishmaniases: Proposals for a Research Agenda
- (2011) et al. PLoS Neglected Tropical Diseases
- Lack of Protection of Pre-Immunization with Saliva of Long-Term Colonized Phlebotomus papatasi against Experimental Challenge with Leishmania major and Saliva of Wild-Caught P. papatasi
- (2010) Sami Ben Hadj Ahmed et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Innate Immunity and Leishmania Vaccination Strategies
- (2010) Ron Birnbaum et al. DERMATOLOGIC CLINICS
- Reverse Vaccinology: Developing Vaccines in the Era of Genomics
- (2010) Alessandro Sette et al. IMMUNITY
- Leishmaniasis vaccines: past, present and future
- (2010) Farrokh Modabber INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Leishmaniasis in the World Health Organization Eastern Mediterranean Region
- (2010) Jose A. Ruiz Postigo INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Leishmaniasis, an emerging infection in travelers
- (2010) Androula Pavli et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
- (2010) Patricia A. Darrah et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vaccination with TAT-Antigen Fusion Protein Induces Protective, CD8+ T Cell-Mediated Immunity Against Leishmania Major
- (2010) Katharina Kronenberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Vaccination with Recombinant Leishmania donovani Gamma-Glutamylcysteine Synthetase Fusion Protein Protects Against L. donovani Infection
- (2010) F. L. Henriquez et al. JOURNAL OF PARASITOLOGY
- Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice
- (2010) T. KAUR et al. PARASITE IMMUNOLOGY
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis
- (2010) Evaldo Nascimento et al. VACCINE
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis
- (2010) Alejandro Llanos-Cuentas et al. VACCINE
- Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE
- (2010) Joelma Trigo et al. VACCINE
- Leishmaniasis: Current Treatment and Prospects for New Drugs and Vaccines
- (2009) Lukasz Kedzierski et al. CURRENT MEDICINAL CHEMISTRY
- AsymptomaticLeishmania infantumInfection in an Area of Northwestern Italy (Piedmont Region) Where Such Infections Are Traditionally Nonendemic
- (2009) Alberto Biglino et al. JOURNAL OF CLINICAL MICROBIOLOGY
- IL-7 Receptor Expression Provides the Potential for Long-Term Survival of Both CD62Lhigh Central Memory T Cells and Th1 Effector Cells during Leishmania major Infection
- (2009) S. L. Colpitts et al. JOURNAL OF IMMUNOLOGY
- Intracellular Replication-Deficient Leishmania donovani Induces Long Lasting Protective Immunity against Visceral Leishmaniasis
- (2009) A. Selvapandiyan et al. JOURNAL OF IMMUNOLOGY
- Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis
- (2009) M. Samant et al. JOURNAL OF IMMUNOLOGY
- Viruses as vaccine vectors for infectious diseases and cancer
- (2009) Simon J. Draper et al. NATURE REVIEWS MICROBIOLOGY
- Canine leishmaniosis in South America
- (2009) Filipe Dantas-Torres Parasites & Vectors
- Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
- (2009) Sudipta Bhowmick et al. PLoS One
- Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process
- (2009) I. Okwor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants
- (2009) J. Poot et al. VACCINE
- Characterization of recombinant influenza A virus as a vector for HIV-1 p17Gag
- (2009) Anna L. de Goede et al. VACCINE
- Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis
- (2009) Iván D. Vélez et al. VACCINE
- Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas
- (2009) Clarisa B. Palatnik-de-Sousa et al. VACCINE
- Optimized subunit vaccine protects against experimental leishmaniasis
- (2009) Sylvie Bertholet et al. VACCINE
- Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis
- (2009) G.P. Borja-Cabrera et al. VACCINE
- Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
- (2009) Nicolas Collin et al. PLoS Pathogens
- Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
- (2009) Nathan C. Peters et al. PLoS Pathogens
- Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research
- (2008) Hong Lin et al. BMC BIOINFORMATICS
- Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
- (2008) Hong Lin et al. BMC IMMUNOLOGY
- Decreased IL-10 and IL-13 production and increased CD44hiT cell recruitment contribute toLeishmania majorimmunity induced by non-persistent parasites
- (2008) Lukasz Kedzierski et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies
- (2008) Ifeoma Okwor et al. IMMUNOLOGIC RESEARCH
- Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model
- (2008) R. Gomes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein
- (2008) Ana Paula Fernandes et al. VACCINE
- Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis
- (2008) Jorge Miret et al. VACCINE
- First generation leishmaniasis vaccines: A review of field efficacy trials
- (2008) Sassan Noazin et al. VACCINE
- Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: Correlation with IFN-γ and cytolytic activity by CD8+ T cells
- (2008) Daniela M. Resende et al. VACCINE
- Complexities of Assessing the Disease Burden Attributable to Leishmaniasis
- (2008) Caryn Bern et al. PLoS Neglected Tropical Diseases
- A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs
- (2007) Rodolfo Cordeiro Giunchetti et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now